Our study showed that the C9BC chimeric promoter could effectively activate downstream gene expression after exposure to 6 Gy of radiation and produce an RNAi effect for targeting LGMN to achieve an effective anti-tumor activity. This evidence concerns the gene LGMN and neoplasm.